Livagen 20 mg research-grade lyophilized peptide powder in a glass vial. Livagen is a synthetic tetrapeptide bioregulator (Lys-Glu-Asp-Ala; also known as KEDA peptide) studied in experimental models focusing on chromatin structure, gene expression and liver-related cellular processes.
Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Purity
99%+ (HPLC, third-party tested)
Form
Lyophilized peptide powder
Content
20 mg Livagen peptide per vial
Packaging
Glass vial with sterile closure
Storage
Store lyophilized at 2–8 °C in a dry, dark place
Molecular formula
C18H31N5O9
Molecular weight
≈ 461.5 g·mol⁻¹
In laboratory workflows, lyophilized research peptides are typically diluted with suitable solvents such as Bacteriostatic water – 10 ml. For diluting lyophilized peptide powders, you need a solution such as
Bacteriostatic water – 10 ml .
Research Overview
Livagen is a short bioregulatory tetrapeptide used in experimental models to investigate chromatin decondensation, gene-expression regulation and age-related changes in liver and immune cells. Laboratory work explores its impact on protein synthesis, cellular repair pathways and tissue-specific regulatory mechanisms in vitro and in vivo research settings.
Primary Research Areas
-
Chromatin structure & gene expression: Experimental models assessing Livagen’s effects on chromatin decondensation, activation of ribosomal genes and transcriptional profiles in aging cells.
-
Liver cell function & regeneration: Hepatocyte and liver-tissue models investigating protein synthesis, cellular homeostasis and potential hepatoprotective mechanisms at the research level.
-
Immune & gastrointestinal models: Studies on short peptide bioregulators examining immune-cell activity, gastrointestinal enzyme regulation and broader systemic adaptation in experimental setups.
